301277 Newland Pharmaceutical
- 14.34
- +0.06+0.42%
Newland Pharmaceutical News
Xintiandi: Announcement on receiving government subsidies
Xintiandi: Announcement on the Use of Some Idle Raised Funds for Cash Management
Xintiandi: Announcement on changes in the company\'s pharmaceutical production license
Xintiandi: Announcement of Resolutions of the Fourth Meeting of the Sixth Board of Supervisors
Xintiandi: Announcement of Resolutions of the Fourth Meeting of the Sixth Board of Directors
Xintiandi: Huatai United Securities Co., Ltd. inspection opinions on the use of some idle funds raised by Xintiandi Pharmaceutical Co., Ltd. for cash management
Xintiandi: Notice on completing registration of industrial and commercial changes and issuing business licenses
Xintiandi: Legal Opinions of Beijing Tianyuan Law Firm on the 2024 Second Extraordinary Shareholders\' Meeting of Xintiandi Pharmaceutical Co., Ltd.
Xintiandi: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Xintiandi: Announcement on Cancelling Some Special Fund Raising Accounts
Xintiandi: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Xintiandi: Supervisory Board Rules of Procedure
Xintiandi: Board of Directors Rules of Procedure
Xintiandi: Announcement of Resolutions of the Third Meeting of the Sixth Board of Directors
Xintiandi: Daily production and operation decision-making system
Xintiandi: Independent Director Work System
Xintiandi: Announcement on the adjustment of product types for some fund-raising projects and the internal investment restructuring and extension of some fund-raising projects
Xintiandi: Huatai United Securities Co., Ltd.\'s inspection opinions on the adjustment of product varieties in some fund-raising projects of Xintiandi Pharmaceutical Co., Ltd., and the internal investment restructuring and extension of some fund-raising projects
Xintiandi: General Manager Work Rules
Xintiandi: Articles of Association
No Data
